This website uses cookies
Read our Privacy policy and Terms of use for more information.
Jul 29, 2026
•
1 min read
Our latest podcast dives into the new app-controlled insulin pump, its unique features, the Simplera and eventual Instinct CGM compatibility, and Smart Guard algorithm.
Jul 23, 2026
Greg Peterson received his first implantable pump in 1992 and has continued to advocate for its development and widespread use ever since.
Jul 20, 2026
Our latest podcast offers a deep dive into the different pumps on the market including the algorithms, form factor, and who they're best suited for.
Jul 10, 2026
We broke down every tubeless pump in development covering form factor and wearability to when we expect them to go to market.
Jul 9, 2026
We break down why carb counting matters for optimal glucose management, tricks for estimating carb counts, and how each macronutrient affects blood sugar.
Jul 2, 2026
Our latest podcast recaps all the tech we saw at ADA's Scientific Sessions from insulin pump developments to updated CGMs and how they will impact diabetes care.
Jun 29, 2026
Commercial airline pilot, John Roth, shares how his T1D diagnosis nearly cost him his career and how he used modern technology to help advocate for change.
Jun 17, 2026
MiniMed came on the podcast to discuss the Flex pump, a new integrated app, and gave us a first look at its first-ever tubeless pump, the Fit.
Jun 12, 2026
Abbott's Libre Duo multianalyte sensors will have the same form factor as the Libre 3 Plus, 15-day wear time and compatibility with several insulin pump manufacturers.
Jun 10, 2026
Patient 9 of the Eledon trial, who received an islet cell transplant, talks about life after being "cured" of type 1 diabetes and the work still left to be done.
Jun 5, 2026
From cause to diagnoses to treatments and tech, there's a lot of similarities and differences between type 1 and type 2 diabetes worth knowing.
Jun 1, 2026
National survey reveals a gap in Type 1 diabetes care at school: while at home students use CGMs and pumps, but most classrooms lag behind forcing parents to intervene.
May 18, 2026
Stash tracks diabetes supplies with barcode scanning, low-stock alerts, trip planning, infusion site-tracking, and recall monitoring.
May 11, 2026
Not all continuous glucose monitors are evaluated equally, and as more people rely on CGMs for insulin dosing, that gap is becoming harder to ignore.
May 4, 2026
Breaking down how the system works with the setup, daily use, algorithm performance, and how it compares to DIY Loop and Omnipod systems.
May 1, 2026
We compare the two most popular CGMs on the market across accuracy, alerts, wear time, and pump compatibility to help you find the right fit for managing diabetes.
Apr 27, 2026
I spoke with Gary Scheiner, CDCES, about why lows happen, how to treat them, and how to use your pump and CGM to reduce their frequency, duration, and severity.
Apr 20, 2026
Civica Rx is a nonprofit selling insulin for $11 a pen and $30 a vial, cutting out the middlemen and pricing games that have kept it unaffordable for decades.
Apr 13, 2026
Nw operating in 20 states and Washington, D.C., Blue Circle Health is expanding free, comprehensive support for adults living with type 1 diabetes across the country.
Apr 10, 2026
We tested the Dexcom G7 15 Day CGM and break down wear performance, accuracy, connectivity and durability, plus we conduct a side-by-side comparison with the 10-day sensor.
Apr 6, 2026
The latest integration marks the first time an implantable continuous glucose monitor has been used to automate insulin delivery with a pump.
Mar 30, 2026
I spoke with Gary Scheiner, CDCES, about optimizing mealtime insulin, including bolus timing, carb ratios, and strategies to reduce post-meal spikes.
Mar 23, 2026
We break down the biggest tech stories from ATTD 2026 with endocrinologist Dr. David Ahn, exploring how fully closed loop systems, smarter sensing, and AI are reshaping the future of diabetes care.
Mar 20, 2026
The MiniMed Flex insulin pump launches in the U.S. this summer and features a smaller and screen-free design, smartphone control, and multiple CGM integrations.
Mar 16, 2026
A bill stalled in Congress and a promising clinical trial may together be the most important developments in type 1 diabetes treatment right now.
